FIELD: medicine.
SUBSTANCE: invention refers to microbiology and veterinary science and aims at treating experimental malleus. Golden hamsters that are animals highly malleus-sensitive, are infected with B.mallei c 5 in dose 104 microbial cells that corresponds to 103 Dim. The treatment starts either 4 hours later and represents an emergency prevention, or 24 h and 48 h later. An antibacterial agent is presented by meropenem in the liposomal form 15 mg in 0.5 ml, in dose 50 mg/kg/day; the preparation is administered intraperitoneally 5 times every 72 hours.
EFFECT: using the method improves the survival rates in animals suffering acute malleus.
2 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SELECTION OF HIGHLY ACTIVE ANTIBACTERIAL MEDICATION FOR TREATMENT OF DISEASES CAUSED BY PATHOGENIC BURKHOLDERIA | 2009 |
|
RU2404252C1 |
| ANTIGENIC PREPARATIONS FOR PREVENTING GLANDERS IN PEOPLE AND ANIMALS | 2004 |
|
RU2262949C1 |
| METHOD OF INDIRECT ESTIMATION OF STRAINS VIRULENCE OF PATHOGENIC BURKHOLDERIA ON GROUNDS OF CYTOPATHOGENICITY | 2012 |
|
RU2485182C1 |
| METHOD OF PRODUCING LIPOSOME WITH ENCAPSULATED DOXYCYCLINE HYDROCHLORIDE AND SURFACE LOCALISED MONOCLONAL ANTIBODIES | 2015 |
|
RU2582969C1 |
| METHOD OF TREATMENT OF EXPERIMENTAL GLANDERS IN GOLDEN HAMSTERS | 1994 |
|
RU2083207C1 |
| METHOD FOR DETERMINING BURKHOLDERIA MALLEI CAPSULAR ANTIGEN IMMUNOGENICITY LEVEL | 2005 |
|
RU2293993C1 |
| CULTURE MEDIUM FOR ISOLATING EQUINIA ACTIVATOR | 2007 |
|
RU2371476C2 |
| COMBINATION OF FULVIC ACID AND ANTIBIOTIC FOR SUPPRESSION OF GROWTH OF BACTERIA RESISTANT TO MAJORITY OF DRUGS, OR TREATMENT OF INFECTIONS CAUSED BY THEM | 2013 |
|
RU2640928C2 |
| METHOD FOR QUICK-TEST DETECTING OF INTRA-HOSPITAL Burkholderia cepacia INFECTION AND ITS DIFFERENTIATION AGAINST OTHER SPECIES OF BURKCHOLDERIA AND PSEUDOMONAS | 2004 |
|
RU2281501C1 |
| METHOD FOR OBTAINING ERYTHROCYTIC ANTIGENIC GLANDEROUS DIAGNOSTIC KIT | 2001 |
|
RU2188036C1 |
